BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21105753)

  • 1. A FRAME response to the Draft Report on Alternative (Non-animal) Methods for Cosmetics Testing: Current Status and Future Prospects--2010.
    Balls M; Clothier R
    Altern Lab Anim; 2010 Oct; 38(5):345-53. PubMed ID: 21105753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The EU Commission's Draft Report on Alternative (Non-animal) Methods for Cosmetics Testing: Current Status and Future Prospects--2010: a missed opportunity.
    Spielmann H
    Altern Lab Anim; 2010 Oct; 38(5):339-43. PubMed ID: 21105752
    [No Abstract]   [Full Text] [Related]  

  • 3. A critique of the EC's expert (draft) reports on the status of alternatives for cosmetics testing to meet the 2013 deadline.
    Taylor K; Casalegno C; Stengel W
    ALTEX; 2011; 28(2):131-48. PubMed ID: 21625829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative (non-animal) methods for cosmetics testing: current status and future prospects-2010.
    Adler S; Basketter D; Creton S; Pelkonen O; van Benthem J; Zuang V; Andersen KE; Angers-Loustau A; Aptula A; Bal-Price A; Benfenati E; Bernauer U; Bessems J; Bois FY; Boobis A; Brandon E; Bremer S; Broschard T; Casati S; Coecke S; Corvi R; Cronin M; Daston G; Dekant W; Felter S; Grignard E; Gundert-Remy U; Heinonen T; Kimber I; Kleinjans J; Komulainen H; Kreiling R; Kreysa J; Leite SB; Loizou G; Maxwell G; Mazzatorta P; Munn S; Pfuhler S; Phrakonkham P; Piersma A; Poth A; Prieto P; Repetto G; Rogiers V; Schoeters G; Schwarz M; Serafimova R; Tähti H; Testai E; van Delft J; van Loveren H; Vinken M; Worth A; Zaldivar JM
    Arch Toxicol; 2011 May; 85(5):367-485. PubMed ID: 21533817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternatives to the use of animals in safety testing as required by the EU-Cosmetics Directive 2009.
    Vogel R
    ALTEX; 2009; 26(3):223-6. PubMed ID: 19907908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A tiered approach to the use of alternatives to animal testing for the safety assessment of cosmetics: genotoxicity. A COLIPA analysis.
    Pfuhler S; Kirst A; Aardema M; Banduhn N; Goebel C; Araki D; Costabel-Farkas M; Dufour E; Fautz R; Harvey J; Hewitt NJ; Hibatallah J; Carmichael P; Macfarlane M; Reisinger K; Rowland J; Schellauf F; Schepky A; Scheel J
    Regul Toxicol Pharmacol; 2010; 57(2-3):315-24. PubMed ID: 20382194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to assess the mutagenic potential of cosmetic products without animal tests?
    Speit G
    Mutat Res; 2009 Aug; 678(2):108-12. PubMed ID: 19379833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuing animal tests on cosmetic ingredients for REACH in the EU.
    Knight J; Rovida C; Kreiling R; Zhu C; Knudsen M; Hartung T
    ALTEX; 2021; 38(4):653-668. PubMed ID: 34402521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human health safety evaluation of cosmetics in the EU: a legally imposed challenge to science.
    Pauwels M; Rogiers V
    Toxicol Appl Pharmacol; 2010 Mar; 243(2):260-74. PubMed ID: 20006634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A tiered approach to the use of alternatives to animal testing for the safety assessment of cosmetics: skin irritation.
    Macfarlane M; Jones P; Goebel C; Dufour E; Rowland J; Araki D; Costabel-Farkas M; Hewitt NJ; Hibatallah J; Kirst A; McNamee P; Schellauf F; Scheel J
    Regul Toxicol Pharmacol; 2009 Jul; 54(2):188-96. PubMed ID: 19393278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recent developments on the European ban on animal experiments for cosmetics].
    Ruhdel IW
    ALTEX; 2001; 18(1):13-6. PubMed ID: 11248844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An expert consortium review of the EC-commissioned report "alternative (Non-Animal) methods for cosmetics testing: current status and future prospects - 2010".
    Hartung T; Blaauboer BJ; Bosgra S; Carney E; Coenen J; Conolly RB; Corsini E; Green S; Faustman EM; Gaspari A; Hayashi M; Wallace Hayes A; Hengstler JG; Knudsen LE; Knudsen TB; McKim JM; Pfaller W; Roggen EL
    ALTEX; 2011; 28(3):183-209. PubMed ID: 21993956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of in vitro cell transformation assays in regulatory toxicology for pharmaceuticals, chemicals, food products and cosmetics.
    Vanparys P; Corvi R; Aardema MJ; Gribaldo L; Hayashi M; Hoffmann S; Schechtman L
    Mutat Res; 2012 Apr; 744(1):111-6. PubMed ID: 22342612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current EU regulatory requirements for the assessment of chemicals and cosmetic products: challenges and opportunities for introducing new approach methodologies.
    Pistollato F; Madia F; Corvi R; Munn S; Grignard E; Paini A; Worth A; Bal-Price A; Prieto P; Casati S; Berggren E; Bopp SK; Zuang V
    Arch Toxicol; 2021 Jun; 95(6):1867-1897. PubMed ID: 33851225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety evaluation of cosmetics in the EU. Reality and challenges for the toxicologist.
    Pauwels M; Rogiers V
    Toxicol Lett; 2004 Jun; 151(1):7-17. PubMed ID: 15177635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Final report of the safety assessment of L-Ascorbic Acid, Calcium Ascorbate, Magnesium Ascorbate, Magnesium Ascorbyl Phosphate, Sodium Ascorbate, and Sodium Ascorbyl Phosphate as used in cosmetics.
    Elmore AR
    Int J Toxicol; 2005; 24 Suppl 2():51-111. PubMed ID: 16154915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative in vitro models used in the main safety tests of cosmetic products and new challenges.
    Filaire E; Nachat-Kappes R; Laporte C; Harmand MF; Simon M; Poinsot C
    Int J Cosmet Sci; 2022 Dec; 44(6):604-613. PubMed ID: 35842748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use and interpretation of in vitro data in regulatory toxicology: cosmetics, toiletries and household products.
    Indans I
    Toxicol Lett; 2002 Feb; 127(1-3):177-82. PubMed ID: 12052656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk assessment of nanomaterials in cosmetics: a European union perspective.
    Henkler F; Tralau T; Tentschert J; Kneuer C; Haase A; Platzek T; Luch A; Götz ME
    Arch Toxicol; 2012 Nov; 86(11):1641-6. PubMed ID: 23052193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of non-animal alternatives in the safety evaluations of cosmetics ingredients by the Scientific Committee on Consumer Safety (SCCS).
    Vinardell MP
    Regul Toxicol Pharmacol; 2015 Mar; 71(2):198-204. PubMed ID: 25555996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.